TL;DR
Researchers have developed a novel mouse model that allows for non-invasive, long-term tracking of specific cell populations within living animals using Positron Emission Tomography (PET). This system combines the Cre/lox genetic system with a PET reporter gene, enabling researchers to visualize and quantify cell behavior in various disease models, offering a significant advancement in understanding complex biological processes.
What Problem Does This Paper Address?
Understanding how specific cell populations behave – their proliferation, migration, and death – is crucial for studying diseases and developing new therapies. Current methods for tracking these cells in vivo are often invasive, lack long-term capabilities, or are semi-quantitative. Existing genetic labeling techniques, while powerful, typically rely on ex vivo analysis or invasive imaging methods. The challenge is to develop a non-invasive, quantitative, and longitudinal method to monitor cell populations and their progeny throughout their lifecycle within a living organism.
Methods
The core innovation is the development of the Rosa26-mT/sr39tk PET reporter mouse. This mouse line has a Cre-inducible thymidine kinase (sr39tk) reporter gene integrated into the ubiquitous Rosa26 locus. The reporter gene is initially silenced by a floxed (LoxP-flanked) cassette encoding a red fluorescent protein (mT). When a Cre recombinase is present (introduced via breeding with a Cre-expressing mouse line), the mT cassette is excised, activating the expression of sr39tk.
This sr39tk enzyme then phosphorylates a PET tracer, [¹⁸F]FHBG, which gets trapped within the cell. This accumulation of the radiotracer allows for detection and quantification of the labeled cells using PET imaging. The system leverages the Cre/lox system's ability to achieve cell-type-specific recombination, meaning that by choosing different Cre-expressing mouse lines, researchers can target and track various cell types, including platelets (using Pf4-Cre), T lymphocytes (using CD4-Cre), and cardiomyocytes (using Myh6-Cre).
Datasets
Not discussed in the paper. The study focuses on developing and validating a new mouse model and imaging technique, rather than training or evaluating on large, pre-existing datasets.
Key Insights and Ideas
- Universal Cell Tracking Potential: The Cre/lox system's versatility means this PET reporter mouse can, in principle, be used to track virtually any cell population for which a Cre mouse line exists, opening up a vast range of research possibilities.
- Longitudinal, Non-Invasive Monitoring: The ability to track cells over weeks in living animals without invasive procedures is a major leap forward, allowing for the study of dynamic processes like immune cell homing and tissue regeneration.
- Uncovering Novel Cre Activity: The PET reporter system proved useful for identifying previously unknown sites of Cre recombinase activity in transgenic mouse lines, highlighting the importance of thorough characterization of Cre driver lines.
- Complementary Imaging: Combining [¹⁸F]FHBG PET (for viable cardiomyocytes) with [¹⁸F]FDG PET (for inflammation/immune cells) offers a powerful way to dissect complex tissue environments, as demonstrated in the myocardial infarction model.
Key Results
- Successful PET Imaging of Multiple Cell Types: The researchers successfully demonstrated longitudinal PET imaging of platelets, T lymphocytes, and cardiomyocytes in their reporter mice.
- T-cell Homing During Inflammation: In a model of allergic contact dermatitis, they tracked T-cell homing to inflamed skin sites over several weeks, showing specific accumulation in challenged ears.
- Cardiomyocyte Viability After Myocardial Infarction (MI): In a mouse model of MI, they were able to visualize and quantify viable cardiomyocytes using [¹⁸F]FHBG PET, distinguishing them from inflammatory cells detected by [¹⁸F]FDG PET.
- Identification of Ectopic Cre Activity: The study identified previously unreported Cre activity in CD4-Cre mice in smooth muscle cells of cardiac blood vessels and in bronchial epithelial cells of the lung, as well as in Myh6-Cre mice in the lung vasculature.
Limitations and Future Work
- Male Infertility: Male R26-mT/sr39tk mice showed severely reduced fertility, necessitating the use of female mice for breeding and maintenance of the line. This is attributed to sr39tk expression from a cryptic promoter in postmeiotic germ cells.
- Potential for Mosaicism with Inducible Cre: When using tamoxifen-inducible Cre lines (like Myh6-CreERT2), labeling can be mosaic, especially in rapidly proliferating cell populations. This can lead to dilution of the reporter signal by non-labeled progeny cells, potentially underestimating cell numbers or viability. The authors suggest using non-inducible Cre lines for more uniform labeling in such cases.
- Background Radioactivity: Non-specific accumulation of [¹⁸F]FHBG in bone and the gastrointestinal tract can complicate imaging. The authors suggest strategies to mitigate this, such as improving tracer purity or using alternative PET tracers with faster clearance.
- Ectopic Cre Activity: While the reporter system can identify ectopic Cre activity, researchers need to be aware of and account for it when designing experiments. Using Cre lines with alternative promoters or more refined Cre drivers is suggested.
- Future Directions: The authors envision broad applicability for this system in studying various diseases, regenerative medicine, and cell-based therapies. They also suggest combining the PET reporter with other imaging modalities and using it for suicide gene therapy applications. The ability to correlate PET data with histochemical analysis (e.g., X-Gal staining) is also highlighted as a valuable validation tool.
Summary updated